Palivizumab prophylaxis in ‘late preterm’ newborns

Complications of the Late Preterm Infant

(2013) Ashley E. Darcy   JOURNAL OF PERINATAL & NEONATAL NURSING

Late Preterm Birth and Neonatal Outcome: Is 37 Weeks’ Gestation a Threshold Level or a Road Marker on the Highway of Perinatal Risk?

(2010) Russell S. Kirby et al.   BIRTH-ISSUES IN PERINATAL CARE

Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33–35 completed weeks’ gestational age in Canada

(2009) Bosco Paes et al.   CURRENT MEDICAL RESEARCH AND OPINION

Neurodevelopmental Outcome of the Premature Infant

(2009) Bonnie E. Stephens et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Annual Summary of Vital Statistics: 2007

(2009) M. Heron et al.   PEDIATRICS

Persistence of Morbidity and Cost Differences Between Late-Preterm and Term Infants During the First Year of Life

(2009) K. K. McLaurin et al.   PEDIATRICS

The Relationship Between Cesarean Delivery and Gestational Age Among US Singleton Births

(2008) Vani R. Bettegowda et al.   CLINICS IN PERINATOLOGY

Development and Validation of a Risk Scoring Tool to Predict Respiratory Syncytial Virus Hospitalization in Premature Infants Born at 33 through 35 Completed Weeks of Gestation

(2008) John S. Sampalis et al.   MEDICAL DECISION MAKING

Effect of Late-Preterm Birth and Maternal Medical Conditions on Newborn Morbidity Risk

(2008) C. K. Shapiro-Mendoza et al.   PEDIATRICS